Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05250648 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05250648 · ClinicalTrials.gov record · last posted 2024-10-09

Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)

Study acronym: GECOP-MMC
StatusRecruiting
PhasePhase 4
Started2022-03-02
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The aim of this study is to assess whether there are differences in PERITONEAL RECURRENCE in patients with Colon Cancer Peritoneal Metastases treated with complete surgical resection and systemic chemotherapy, with (Group 1) or without (Group 2) HIPEC with Mitomycin-C.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2022-02-20; most recent amendment 2024-10-06. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-09-10
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05250648
Lead Sponsor Hospital Universitario de Fuenlabrada
Collaborators: Instituto de Investigación Hospital Universitario La Paz
Conditions Peritoneal Carcinomatosis, Colon Cancer
Enrollment 216 participants
Start Date 2022-03-02
Primary Completion 2029-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2024-10-09